suggest
origin
bat
howev
one
diseas
report
direct
contact
bat
battohuman
transmiss
seem
unlik
larg
geograph
area
merscov
outbreak
across
arabian
peninsula
sequenc
variat
isol
project
date
emerg
time
fi
rst
human
case
report
suggest
multipl
zoonot
introduct
merscov
could
indic
involv
intermedi
host
lancet
infecti
diseas
chantal
reusken
colleagu
provid
insight
one
potenti
anim
reservoir
might
involv
emerg
merscov
peoplefor
fi
rst
time
sinc
discoveri
viru
year
ago
detect
neutralis
antibodi
serum
sampl
dromedari
camel
collect
oman
march
surprisingli
dromedari
camel
canari
island
spain
also
antibodi
serum
sampl
collect
variou
livestock
speci
contain
merscovspecifi
c
antibodi
although
collect
area
camel
therebi
potenti
indic
geograph
rather
host
restrict
whether
camel
infect
merscov
close
relat
viru
unclear
human
case
infect
report
oman
far
despit
proxim
countri
human
case
high
preval
neutralis
antibodi
viru
local
camel
popul
detect
sequenc
similar
merscov
bat
africa
america
eurasia
presenc
neutralis
antibodi
camel
canari
island
suggest
merscovlik
virus
wide
geograph
distribut
absenc
associ
high
preval
neutralis
antibodi
morbid
mortal
camel
suggest
circul
merscovlik
virus
camel
might
go
undetect
fact
beg
question
whether
detect
merscov
neutralis
antibodi
camel
spain
oman
result
unrel
crossspeci
transmiss
event
whether
viru
circul
camel
long
time
regardless
chang
ecolog
merscov
must
occur
enabl
emerg
peopl
chang
could
genet
enabl
viru
effi
cientli
replic
human
respiratori
tract
happen
sever
acut
respiratori
syndrom
coronaviru
acquir
abil
bind
human
altern
environment
agricultur
chang
could
enabl
introduct
merscov
new
host
speci
similar
establish
pig
farm
malaysia
enabl
crossspeci
transmiss
nipah
viru
pig
subsequ
spillov
peopl
report
reusken
colleagu
stress
urgent
need
integr
one
health
approach
public
veterinari
health
stakehold
involv
countri
combin
rapid
dissemin
data
extens
serosurvey
done
across
arabian
peninsula
peopl
livestock
wild
anim
speci
combin
virolog
test
possibl
identifi
potenti
reservoir
merscov
absenc
prophylact
therapeut
treatment
option
merscov
block
zoonot
humantohuman
transmiss
could
promis
costeff
ectiv
method
prevent
human
fatal
howev
requir
knowledg
viru
host
although
studi
reusken
colleagu
leav
mani
question
unansw
import
step
comprehens
understand
emerg
merscov
articl
mikhail
v
edelstein
colleagu
publish
lancet
infecti
diseas
serv
warn
bad
antibiot
resist
becom
research
describ
major
hospit
epidem
clone
pseudomona
aeruginosa
spread
within
year
throughout
belaru
kazakhstan
russia
although
origin
environment
bacteria
littl
harm
healthi
peopl
p
aeruginosa
gain
frighten
reput
caus
sever
infect
peopl
impair
immun
system
eg
cystic
fi
brosi
burn
leukaemia
undergo
invas
procedur
third
common
caus
nosocomi
infect
escherichia
coli
staphylococcu
aureu
p
aeruginosa
propens
acquir
antibioticresist
mechan
antibiot
activ
long
time
carbapenem
last
line
treatment
howev
mani
p
aeruginosa
strain
edelstein
colleagu
studi
resist
carbapenem
result
product
enzym
hydrolys
carbapenem
render
member
antibiot
famili
